Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis

Journal of Ovarian Research

John F McDonald³  Benedict B Benigno³  Stephen L Wells²  L DeEtte Walker¹  Lilya V Matyunina¹  Loukia N Lili¹ 

[1] Integrated Cancer Research Center, School of Biology, and Parker H. Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, 315 Ferst Dr., Atlanta, GA 30332, USA;Northside Hospital, 1000 Johnson Ferry Rd, Atlanta, GA 30342, USA;Ovarian Cancer Institute, 960 Johnson Ferry Rd, Suite 130, Atlanta GA 30342, USA

关键词: Ovarian cancer;    EMT;    Epithelial-to-mesenchymal transition;    Metastasis;   

Others  :  810278
DOI  :  10.1186/1757-2215-6-49

 received in 2013-06-17, accepted in 2013-07-08,  发布年份 2013

【 摘 要 】

Background

While metastasis ranks among the most lethal of all cancer-associated processes, on the molecular level, it remains one of the least well understood. One model that has gained credibility in recent years is that metastasizing cells at least partially recapitulate the developmental process of epithelial-to-mesenchymal transition (EMT) in their transit from primary to metastatic sites. While experimentally supported by cell culture and animal model studies, the lack of unambiguous confirmatory evidence in cancer patients has led to persistent challenges to the model’s relevance in humans.

Methods

Gene expression profiling (Affymetrix, U133) was carried out on 14 matched sets of primary (ovary) and metastatic (omentum) ovarian cancer (serous adenocarcinoma) patient samples. Hierarchical clustering and functional pathway algorithms were used in the data analysis.

Results

While histological examination reveled no morphological distinction between the matched sets of primary and metastatic samples, gene expression profiling clearly distinguished two classes of metastatic samples. One class displayed expression patterns statistically indistinguishable from primary samples isolated from the same patients while a second class displayed expression patterns significantly different from primary samples. Further analyses focusing on genes previously associated with EMT clearly distinguished the primary from metastatic samples in all but one patient.

Conclusion

Our results are consistent with a role of EMT in most if not all ovarian cancer metastases and demonstrate that identical morphologies between primary and metastatic cancer samples is insufficient evidence to negate a role of EMT in the metastatic process.

【 授权许可】

   
2013 Lili et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Levayer R, Lecuit T: Breaking down EMT. Nat Cell Biol 2008, 10:757-759.
• [2]Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
• [3]Valastyan S, Weinberg RA: Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
• [4]Brabletz T: EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 2012, 22:699-701.
• [5]Chaffer CL, Brennan JP, Slavin JL, Bick T, Thompson EW, Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 2006, 66:11271-11278.
• [6]Marian CO, Yang L, Zou YS, Gore C, Pong RC, Shay JW, Kabbani W, Hsieh JT, Raj GV: Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line. Prostate 2011, 71:626-636.
• [7]Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acioque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA: Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012, 22:709-724.
• [8]Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J: Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012, 22:725-736.
• [9]Tarin D, Thompson EW, Newgreen DF: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000.
• [10]Ledford H: Cancer theory faces doubts. Nature 2011, 472:273.
• [11]Monteiro J, Fodde R: Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer 2010, 46:1198-1203.
• [12]Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
• [13]Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF: Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2009, 2:71-82. BioMed Central Full Text
• [14]Chaffer L, Weinberg RA: A perspective on cancer metastasis. Science 2011, 331:1559-1564.